Search results
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 weeks agoVertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic...
Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development
Zacks via Yahoo Finance· 1 month agoVertex (VRTX) advances inaxaplin to late-stage development. It will evaluate the drug in lower age...
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
Zacks via Yahoo Finance· 1 month agoVertex Pharmaceuticals Incorporated VRTX enjoys a dominant position in the cystic fibrosis (CF)...
Vertex (VRTX) Hits Record High on Non-Opioid Pain Drug Data
Zacks via Yahoo Finance· 5 months agoVertex (VRTX) stock hits a 52-week high after announcing encouraging data from a phase II study on...
Vertex Towers takes Hampton to court over rejected 156-foot cell tower
Portsmouth Herald via Yahoo News· 1 month agoHAMPTON — Vertex Towers is suing the town’s Zoning Board over its January vote to reject its...
Vertex (VRTX) Gets Nod in EU for Orkambi Expanded Indication
Zacks via Yahoo Finance· 10 months agoVertex's (VRTX) Orkambi gets approval from the European Commission in the EU for the treatment of...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 months agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) maintains a robust market position with a focus on cystic...
Don't miss the last chance to grab tickets for Vertex 2024
Creative Bloq via Yahoo News· 3 weeks agoVertex 2024 logo. Vertex 2024, the ultimate in-person event for 2D and 3D digital art, will bring...
Got $1,000? 2 No-Brainer Stocks to Buy
Motley Fool· 7 months agoLet's look at two stocks that fit this description: Vertex Pharmaceuticals (NASDAQ: VRTX) and Visa (NYSE: V). One of the keys to success as a biotech...
2 Nasdaq Growth Stocks That Are Screaming Buys in April
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) -- are particularly...
